Penwest Pharmaceuticals is engaged in the research, development and commercialization of novel drug delivery technologies and has extensive expertise in developing and manufacturing excipient ingredients for the pharmaceutical industry. Based on this fundamental expertise in tabletting ingredients, the company has developed its proprietary TIMERx controlled release drug delivery technology, which is applicable to a broad range of orally administered drugs, and ProSolv a co-processing drug deliverytechnology platform.